|
| [February 04, 2013] |
 |
CRF Health becomes the first to achieve Gold Standard with complete validation of Professor Juniper's ACQ and AQLQ ePRO instruments on the TrialMax® Platform
PLYMOUTH MEETING, Pa. --(Business Wire)--
CRF
Health, the developer of the TrialMax®
Suite of electronic Clinical Outcome Assessment Solutions (eCOA) for
the life sciences industry, becomes the first eCOA company to complete a
full validation study for Professor Juniper's ACQ and AQLQ
questionnaires to the "Gold Standard" based on her recently released
"Levels of Acceptability of Electronic Versions" rating system. CRF
Health continually collaborates with instrument authors to achieve the
highest level of compliance with their instruments to assure data
integrity.
CRF Health has now deployed spirometer integration together with the ACQ
and AQLQ in several global studies on TrialMax
Touch™ and TrialMax
Slate™ with four major Pharmaceutical companies. Including these
programs, CRF Health's clinical reach and breadth using Professor
Juniper's instruments spans nearly 40 countries, 3000 patients, and more
than 40 languages. In addition to these, CRF Health has deployed a
further 15 studies using Professor Juniper's ACQ and AQLQ instruments
(but without spirometer integration).
TrialMax®
solutions are available for 5 platforms including Windows, Windows
Mobile, Android (News - Alert), Palm OS and Web, thus allowing clients to select the
right platform, technology and hardware to support their clinical
trials. The combination of CRF Health's clinical expertise and
innovation of ePRO collection methods, combined with patient engagement
and retention tools, offer new ways to improve study execution and
subject compliance.
In a recent study discussion, Professor Elizabeth Juniper commented, "I
feel it is important, when evaluating a new technology device to
determine whether it will give valid data, to keep in mind that validity
is more liely to be achieved if the screen shots are similar to the
original format especially when translating languages with longer text."
As the most flexible eCOA solution in the industry, TrialMax offers
superior usability to patients, sites and sponsors. CRF Health's
flexible, collaborative design tool, TrialStudio®,
facilitates the rapid implementation of electronic Patient Reported
Outcome instruments. By leveraging the TrialMax®
Suite, CRF Health is clearly the leader in maintaining the integrity
of instrument authors' research and designs. In addition, the provision
of world class support to patients, clinicians, sites and sponsors
ensures high levels of usability and compliance.
"Professor Elizabeth Juniper's diligence and research integrity is a
model for the industry. We are excited to have had the opportunity to
collaborate and to jointly achieve this industry milestone. It is
through our engagement with researchers and instrument authors such as
Professor Elizabeth Juniper that we continually enhance our regulatory
rigor, technology competence and patient research integrity through clinical
expertise and innovation,"
commented Rachael
Wyllie, CEO of CRF Health.
About Professor Elizabeth Juniper
Elizabeth F. Juniper, MCSP, MSc. is Professor Emeritus, Department of
Clinical Epidemiology and Biostatistics, McMaster University, Canada.
Professor Juniper trained as a physiotherapist and later, while at the
Royal Postgraduate Medical School, took a degree in Medical Physics and
Physiological Measurement. In 1973, she emigrated to McMaster University
in Canada where her primary interest was in asthma and rhinitis
research. Over the next decade, she was first author of classic methods
papers on the measurement of airway hyperresponsiveness and she
designed, conducted and published a large number of clinical trials both
in asthma and rhinoconjunctivitis. Following her further degree in
clinical epidemiology and biostatistics, her interest turned to the
development of methods to measure subjective health status. Her asthma
and rhinitis quality of life questionnaires as well as her Asthma
Control Questionnaire are now used throughout the world both in research
and clinical practice.
About CRF Health
CRF
Health delivers electronic Clinical
Outcome Assessment (eCOA) solutions for global clinical trials. The
most innovative Pharmaceutical and Biotechnology companies partner with
CRF Health to develop electronic Clinical
Outcome Assessment strategies, transition from legacy paper
instruments, and manage Clinical Outcome data to gain immediate visibility
to patient assessments.
By means of our expertise and technologies we bridge the barriers to
securely deliver best practice eCOA solutions for the life sciences
industry, improving patient compliance, data integrity and mitigating
the regulatory risks of paper based clinical outcomes assessments. eCOA
solutions encompass PROs (Patient Reported Outcomes), ObsROs (Observer
Reported Outcomes) and ClinROs (Clinician or Rater Reported Outcomes).
CRF Health has initiated over 400 trials in over 70 countries and 150
languages and regional dialects, including several regional Indian
dialects; consistently demonstrating the industry's highest patient
compliance rates, while delivering unrivaled data accuracy and unmatched
patient and site acceptance.
CRF Health, TrialMax and TrialMax Touch are trademarks of CRF Health
Inc. Android is a trademark of Google Inc. Windows and Windows Mobile
are both trademarks of Microsoft (News - Alert) Corporation in the United States and
other countries. Palm OS is a trademark of Palm Holdings.
[ Back To Mobile Security Homepage's Homepage ]
|
Follow Us